Investing.com - Financial Markets Worldwide
🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Siemens Healthineers raises 2022 outlook on demand for COVID-19 tests

Published 05/04/2022, 01:24 AM
Updated 05/04/2022, 01:37 AM
© Reuters. FILE PHOTO: An employee wearing a face mask is seen at a workshop of computed tomography (CT) scanners of medical device firm Siemens Healthineers in Shanghai, China, February 24, 2020. REUTERS/Aly Song

(Corrects to show revenue rose in second quarter, not first quarter, of 2022 financial year in paragraph 1)

BERLIN (Reuters) - U.S.-German medical device maker Siemens Healthineers raised its targets for the 2022 financial year on Wednesday due to increased demand for rapid COVID-19 antigen tests, and reported a rise in second-quarter revenue and earnings.

The company said it now expected its diagnostics segment to generate around 1.3 billion euros ($1.37 billion) in revenue with rapid COVID-19 antigen tests, up from some 700 million euros previously.

As a result, it expected comparable revenue growth of between 5.5% and 7.5%, up from 3% to 5% previously, and adjusted basic earnings per share of between 2.25 and 2.35 euros, up from 2.18 to 2.30 euros previously.

© Reuters. FILE PHOTO: An employee wearing a face mask is seen at a workshop of computed tomography (CT) scanners of medical device firm Siemens Healthineers in Shanghai, China, February 24, 2020. REUTERS/Aly Song

"Our business continues to show great resilience in the face of unprecedented challenges. On this foundation, and thanks to high demand for our rapid antigen tests, we are raising our outlook for the current financial year," CEO Bernd Montag said.

(Corrects to show revenue rose in second quarter, not first quarter, of 2022 financial year in paragraph 1)

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.